Preferred Label : receptor, igf type 1;
MeSH definition : A protein-tyrosine kinase receptor that is closely related in structure to the INSULIN
RECEPTOR. Although commonly referred to as the IGF-I receptor, it binds both IGF-I
and IGF-II with high affinity. It is comprised of a tetramer of two alpha and two
beta subunits which are derived from cleavage of a single precursor protein. The beta
subunit contains an intrinsic tyrosine kinase domain.;
MeSH synonym : receptor, igf-1; receptor, insulin-like growth factor type 1; receptors, igf-1; receptors, insulin-like-growth factor i; igf-i receptor; igf-1 receptor; igf-1 receptors; insulin like growth factor i receptor; igf i receptor; insulin-like-growth factor i receptor; receptor, igf i; igf 1 receptor; receptor, igf-i; receptor, insulin-like growth factor i; receptors, igf 1; igf type 1 receptor;
CISMeF synonym : EC 2.7.1.112; EC 2.7.11.-;
MeSH hyponym : receptor, IGF type 1 alpha subunit; receptor, IGF type 1 beta subunit;
Registry Number MeSH : EC 2.7.10.1;
MeSH annotation : DF: RECEPT IGF 1;
Is substance : O;
UNII : EC 2.7.10.1;
Origin ID : D017526;
UMLS CUI : C0140080;
Allowable qualifiers
CISMeF manual mappings
Indexing information
- GTx 134 [MeSH Supplementary Concept]
Record concept(s)
Related MeSH Supplementary Concept(s)
See also
Semantic type(s)
UMLS correspondences (same concept)
A protein-tyrosine kinase receptor that is closely related in structure to the INSULIN
RECEPTOR. Although commonly referred to as the IGF-I receptor, it binds both IGF-I
and IGF-II with high affinity. It is comprised of a tetramer of two alpha and two
beta subunits which are derived from cleavage of a single precursor protein. The beta
subunit contains an intrinsic tyrosine kinase domain.
https://www.ema.europa.eu/en/medicines/human/EPAR/tepezza
2025
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
graves ophthalmopathy
adult
infusions, intravenous
antibodies, monoclonal, humanized
antibodies, monoclonal, humanized
teprotumumab
teprotumumab
teprotumumab
Product containing only teprotumumab in parenteral dose form (medicinal product form)
receptor, igf type 1
Anti-IGF1R Monoclonal Antibody
product surveillance, postmarketing
pregnancy
drug evaluation, preclinical
drug storage
---